Skip to main content
SpringerLink
Log in

Pancreatic Cancer Screening

  • Chapter
  • First Online:
Pancreatic Cancer: A Multidisciplinary Approach

  • 544 Accesses

Abstract

Multiple centers across the world have developed pancreatic cancer (PC) screening programs for high-risk individuals with the aim to detect precursor lesions or PC in an early and potentially curable stage. Even though there is limited data suggesting that screening may improve survival, selective screening of high-risk individuals is considered beneficial. Screening for PC should preferably be performed at major centers with multidisciplinary screening program or in the setting of research protocols. This chapter will review data about risk factors and genetic predisposition for PC, will provide current information on PC precursor lesions, and highlight current screening strategies and preliminary results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National Cancer Institute. Surveillance, epidemiology, and end results (SEER) program. Cancer Stat Facts: pancreatic cancer. 2020.

    Google Scholar 

  2. Ferlay J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.

    Article  CAS  PubMed  Google Scholar 

  3. Jung KW, et al. Clinicopathological aspects of 542 cases of pancreatic cancer: a special emphasis on small pancreatic cancer. J Korean Med Sci. 2007;22(Suppl):S79–85.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Egawa S, et al. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28(3):235–40.

    Article  PubMed  Google Scholar 

  5. Egawa S, et al. Japan pancreatic cancer registry; 30th year anniversary: Japan pancreas society. Pancreas. 2012;41(7):985–92.

    Article  PubMed  Google Scholar 

  6. Tempero MA. NCCN guidelines updates: pancreatic cancer. J Natl Compr Cancer Netw. 2019;17(5.5):603–5.

    CAS  Google Scholar 

  7. Pourshams A, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934–47.

    Article  Google Scholar 

  8. Wiest NE, et al. Screening for pancreatic cancer: a review for general clinicians. Romanian Journal of Internal Medicine. 2020;58(3):119–28.

    Article  PubMed  Google Scholar 

  9. Lynch SM, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170(4):403–13.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nöthlings U, et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst. 2005;97(19):1458–65.

    Article  PubMed  Google Scholar 

  11. Bosetti C, et al. Cigarette smoking and pancreatic cancer: an analysis from the international pancreatic cancer case-control consortium (Panc4). Ann Oncol. 2012;23(7):1880–8.

    Article  CAS  PubMed  Google Scholar 

  12. Fuchs CS, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156(19):2255–60.

    Article  CAS  PubMed  Google Scholar 

  13. Lucenteforte E, et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the international pancreatic cancer case–control consortium (PanC4). Ann Oncol. 2012;23(2):374–82.

    Article  CAS  PubMed  Google Scholar 

  14. Genkinger JM, et al. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol. 2015;26(11):2257–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Michaud DS, et al. Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am J Epidemiol. 2003;157(12):1115–25.

    Article  PubMed  Google Scholar 

  16. Rohrmann S, et al. Meat and fish consumption and risk of pancreatic cancer: results from the European prospective investigation into cancer and nutrition. Int J Cancer. 2013;132(3):617–24.

    Article  CAS  PubMed  Google Scholar 

  17. Xu J-H, et al. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013;19(26):4234.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Luo G, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2013;24(3):529–37.

    Article  PubMed  Google Scholar 

  19. Schulte A, et al. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control. 2015;26(7):1027–35.

    Article  PubMed  Google Scholar 

  20. Bracci PM, et al. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control. 2009;20(9):1723–31.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Batabyal P, et al. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol. 2014;21(7):2453–62.

    Article  PubMed  Google Scholar 

  22. Elena JW, et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control. 2013;24(1):13–25.

    Article  PubMed  Google Scholar 

  23. Canto MI. Familial risk factors for pancreatic cancer and screening of high-risk patients. UpToDate, 2020.

    Google Scholar 

  24. Giardiello FM, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119(6):1447–53.

    Article  CAS  PubMed  Google Scholar 

  25. Goldstein AM, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations. N Engl J Med. 1995;333(15):970–5.

    Article  CAS  PubMed  Google Scholar 

  26. de Snoo FA, et al. Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res. 2008;14(21):7151–7.

    Article  PubMed  Google Scholar 

  27. Lynch HT, et al. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships. Cancer Genet Cytogenet. 2005;158(2):119–25.

    Article  CAS  PubMed  Google Scholar 

  28. Hu C, et al. Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA. 2018;319(23):2401–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hu C, et al. Multigene hereditary cancer panels reveal high-risk pancreatic cancer susceptibility genes. JCO Precis Oncol. 2018;2:1–28.

    Google Scholar 

  30. Iqbal J, et al. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2012;107(12):2005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kastrinos F, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009;302(16):1790–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Lowenfels AB, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International hereditary pancreatitis study group. J Natl Cancer Inst. 1997;89(6):442–6.

    Article  CAS  PubMed  Google Scholar 

  33. Rebours V, et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol. 2008;103(1):111.

    Article  PubMed  Google Scholar 

  34. Aslanian HR, Lee JH, Canto MI. AGA clinical practice update on pancreas cancer screening in high risk individuals: expert review. Gastroenterology. 2020;159(1):358–62.

    Article  CAS  PubMed  Google Scholar 

  35. Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology. 2010;139(4):1076–1080.e2.

    Article  PubMed  Google Scholar 

  36. Brune KA, et al. Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst. 2010;102(2):119–26.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kim JY, Hong SM. Precursor lesions of pancreatic cancer. Oncol Res Treat. 2018;41(10):603–10.

    Article  PubMed  Google Scholar 

  38. Abramson MA, et al. The molecular biology of pancreatic cancer. Gastrointest Cancer Res. 2007;1(4 Suppl 2):S7.

    PubMed  PubMed Central  Google Scholar 

  39. Fonseca AL, et al. Intraductal papillary mucinous neoplasms of the pancreas: current understanding and future directions for stratification of malignancy risk. Pancreas. 2018;47(3):272–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Fischer CG, et al. Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations. Gastroenterology. 2019;157(4):1123–1137.e22.

    Article  CAS  PubMed  Google Scholar 

  41. Naveed S, et al. Mucinous cystic neoplasms of pancreas. Gastroenterology Res. 2014;7(2):44.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Zamboni G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23(4):410–22.

    Article  CAS  PubMed  Google Scholar 

  43. Goggins M, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the international cancer of the pancreas screening (CAPS) consortium. Gut. 2020;69(1):7–17.

    Article  CAS  PubMed  Google Scholar 

  44. Ogawa Y, et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer. 2002;94(9):2344–9.

    Article  PubMed  Google Scholar 

  45. Illés D, et al. New-onset type 2 diabetes mellitus–a high-risk group suitable for the screening of pancreatic cancer? Pancreatology. 2016;16(2):266–71.

    Article  PubMed  Google Scholar 

  46. Săftoiu A, et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European society of gastrointestinal endoscopy (ESGE) position statement. Endoscopy. 2020;52(04):293–304.

    Article  PubMed  Google Scholar 

  47. Daly MB, et al. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(1):77–102.

    Article  CAS  Google Scholar 

  48. Canto MI, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142(4):796–804.

    Article  PubMed  Google Scholar 

  49. Harinck F, et al. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut. 2016;65(9):1505–13.

    Article  CAS  PubMed  Google Scholar 

  50. Brune K, et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006;30(9):1067–76.

    PubMed  PubMed Central  Google Scholar 

  51. O'Brien DP, et al. Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Clin Cancer Res. 2015;21(3):622–31.

    Article  PubMed  Google Scholar 

  52. Stoffel EM, et al. Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion. J Clin Oncol. 2019;37(2):153–64.

    Article  PubMed  Google Scholar 

  53. Force UPST. Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement. JAMA. 2019;322(5):438–44.

    Article  Google Scholar 

  54. Canto MI, et al. Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology. 2018;155(3):740–751.e2.

    Article  PubMed  Google Scholar 

  55. Canto MI, et al. Surgical outcomes after pancreatic resection of screening-detected lesions in individuals at high risk for developing pancreatic cancer. J Gastrointest Surg. 2020;24(5):1101–10.

    Article  PubMed  Google Scholar 

  56. Vasen H, et al. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers. J Clin Oncol. 2016;34(17):2010–9.

    Article  CAS  PubMed  Google Scholar 

  57. Springer S, et al. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019;11(501):eaav4772.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Lennon AM, Hruban RH, Klein AP. Screening for pancreatic cancer—is there hope? JAMA Intern Med. 2019;179(10):1313–5.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Cazacu I, et al. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: a systematic review. Endosc Ultrasound. 2019;8(1):17–24.

    Article  PubMed  Google Scholar 

  60. Konings IC, et al. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology. 2016;25(8):971–8.

    Article  PubMed  Google Scholar 

  61. Hart SL, et al. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psychooncology. 2012;21(12):1324–30.

    Article  PubMed  Google Scholar 

  62. Cazacu IM, et al. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endosc Ultrasound. 2020;9(1):53–8.

    Article  PubMed  Google Scholar 

  63. Zhu M, et al. Differentiation of pancreatic cancer and chronic pancreatitis using computer-aided diagnosis of endoscopic ultrasound (EUS) images: a diagnostic test. PLoS One. 2013;8(5):e63820.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Săftoiu A, et al. Quantitative contrast-enhanced harmonic EUS in differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc. 2015;82(1):59–69.

    Article  PubMed  Google Scholar 

  65. Muhammad W, et al. Pancreatic cancer prediction through an artificial neural network. Front Artif Intell. 2019;2:2.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Hasan S, et al. Advances in pancreatic cancer biomarkers. Oncol Rev. 2019;13(1):410.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Titu Maiorescu University, Department of Oncology, Fundeni Clinical Institute, Bucharest, Romania

    Irina M. Cazacu

  2. Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Ben S. Singh

  3. Carol Davila University of Medicine and Pharmacy, Department of Gastroenterology, Elias Emergency University Hospital, Bucharest, Romania

    Adrian Saftoiu

  4. Department of Clinical Cancer Prevention and Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Florencia McAllister

  5. Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Manoop S. Bhutani

Authors
  1. Irina M. Cazacu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ben S. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Florencia McAllister
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adrian Saftoiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manoop S. Bhutani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manoop S. Bhutani .

Editor information

Editors and Affiliations

  1. Department of Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Manoop S. Bhutani

  2. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Matthew H.G. Katz

  3. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Anirban Maitra

  4. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Joseph M. Herman

  5. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Robert A. Wolff

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cazacu, I.M., Singh, B.S., McAllister, F., Saftoiu, A., Bhutani, M.S. (2022). Pancreatic Cancer Screening. In: Bhutani, M.S., Katz, M.H., Maitra, A., Herman, J.M., Wolff, R.A. (eds) Pancreatic Cancer: A Multidisciplinary Approach. Springer, Cham. https://doi.org/10.1007/978-3-031-05724-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-05724-3_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-05723-6

  • Online ISBN: 978-3-031-05724-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation